Labcorp (LH) news
Recent news
JPMorgan raises Labcorp target price to $360 from $330
JPMorgan has raised its price target for Labcorp Holdings (LH) to $360 from $330, reflecting a 9.09% increase in valuation . This adjustment aligns with broader analyst sentiment, as multiple firms have recently revised their price targets upward. For instance, Barclays increased its target to $320…
AInvest Wire · Aug 3, 2026LabCorp exec says assumption for about 30 basis points impact to 2026 diagnostics volume from ACA-related changes remains appropriate - conf call
LabCorp Holdings Inc. (NYSE: LH) has maintained its assumption that the Affordable Care Act (ACA) related changes will result in a 30 basis point impact on diagnostics volume for 2026, according to remarks made during the company’s Q1 2026 earnings call. This estimate is factored into the company’s…
AInvest Wire · Jul 30, 2026LabCorp exec says specialty testing business continues to grow faster than routine testing business, expects trend to continue - conf call
LabCorp executives highlighted during a recent conference call that the company’s specialty testing business is growing at a faster pace than its routine testing segment, a trend they anticipate will continue in the coming years. This shift reflects broader industry dynamics, including expansion of…
AInvest Wire · Jul 30, 2026LabCorp sees FY revenue $14.71B to $14.83B, saw $14.65B to $14.80B
AInvest Wire · Jul 30, 2026LabCorp announces 2026 second quarter results; raises full year 2026 guidance
AInvest Wire · Jul 30, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.